{"id":"sparfloxacin","rwe":[],"tags":[{"label":"High Risk QT Prolonging Agents","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Potassium voltage-gated channel subfamily H member 2","category":"target"},{"label":"KCNH2","category":"gene"},{"label":"J01MA09","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Active","category":"status"},{"label":"Acute Moraxella catarrhalis bronchitis","category":"indication"},{"label":"Acute bacterial bronchitis","category":"indication"},{"label":"Bacterial infection due to Klebsiella pneumoniae","category":"indication"},{"label":"Chlamydia Pneumoniae Bronchitis","category":"indication"},{"label":"Chlamydial pneumonia","category":"indication"},{"label":"Enterobacter Cloacae Bronchitis","category":"indication"},{"label":"Approved 1990s","category":"decade"},{"label":"Anti-Bacterial Agents","category":"pharmacology"},{"label":"Anti-Infective Agents","category":"pharmacology"},{"label":"Antineoplastic Agents","category":"pharmacology"},{"label":"Antitubercular Agents","category":"pharmacology"},{"label":"Enzyme Inhibitors","category":"pharmacology"},{"label":"Topoisomerase II Inhibitors","category":"pharmacology"},{"label":"Topoisomerase Inhibitors","category":"pharmacology"}],"phase":"marketed","safety":{"drugInteractions":[{"url":"/drug/high-risk-qt-prolonging-agents","drug":"High Risk QT Prolonging Agents","action":"Avoid combination","effect":"Highest Risk QTc-Prolonging Agents may enhance the QTc-prolonging effect of other Highest Risk QTc-Prolonging Agents","source":"DrugCentral","drugSlug":"high-risk-qt-prolonging-agents"},{"url":"/drug/sucralfate","drug":"sucralfate","action":"Monitor closely","effect":"May interact with Sucralfate","source":"DrugCentral","drugSlug":"sucralfate"},{"url":"/drug/ziprasidone","drug":"ziprasidone","action":"Avoid combination","effect":"May interact with Ziprasidone","source":"DrugCentral","drugSlug":"ziprasidone"}]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=SPARFLOXACIN","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:37:19.412252+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:37:33.068550+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=SPARFLOXACIN","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:37:34.089145+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Bacterial DNA gyrase inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:37:34.849204+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL850/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:37:34.685582+00:00"}},"allNames":"sparcin","offLabel":[],"synonyms":["sparfloxacin","sparcin","PD 131501","AT-4140","CI-978"],"timeline":[{"date":"1996-12-19","type":"positive","source":"DrugCentral","milestone":"FDA approval"}],"aiSummary":"Sparcin is a small molecule inhibitor of the molecular target Topoisomerase IV. It belongs to the drug class of inhibitors and works by inhibiting Topoisomerase IV.","approvals":[{"date":"1996-12-19","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Sparcin","ecosystem":[{"indication":"Acute Moraxella catarrhalis bronchitis","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"cefaclor","slug":"cefaclor","company":""},{"name":"cefdinir","slug":"cefdinir","company":""},{"name":"cefpodoxime proxetil","slug":"cefpodoxime-proxetil","company":""}],"globalPrevalence":null},{"indication":"Acute bacterial bronchitis","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"azithromycin","slug":"azithromycin","company":""},{"name":"cefaclor","slug":"cefaclor","company":""},{"name":"cefixime","slug":"cefixime","company":""}],"globalPrevalence":null},{"indication":"Bacterial infection due to Klebsiella pneumoniae","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"amikacin","slug":"amikacin","company":"Apothecon"},{"name":"azlocillin","slug":"azlocillin","company":"Bayer Pharmaceuticals Corp"},{"name":"aztreonam","slug":"aztreonam","company":"Bristol Myers Squibb"}],"globalPrevalence":null},{"indication":"Chlamydia Pneumoniae Bronchitis","otherDrugs":[{"name":"norfloxacin","slug":"norfloxacin","company":""}],"globalPrevalence":null},{"indication":"Chlamydial pneumonia","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"azithromycin","slug":"azithromycin","company":""},{"name":"clarithromycin","slug":"clarithromycin","company":"Abbvie"},{"name":"erythromycin","slug":"erythromycin","company":"Arbor Pharms Llc"}],"globalPrevalence":null},{"indication":"Enterobacter Cloacae Bronchitis","otherDrugs":[{"name":"aztreonam","slug":"aztreonam","company":"Bristol Myers Squibb"},{"name":"norfloxacin","slug":"norfloxacin","company":""}],"globalPrevalence":null},{"indication":"Haemophilus Influenzae Bronchitis","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"aztreonam","slug":"aztreonam","company":"Bristol Myers Squibb"},{"name":"cefaclor","slug":"cefaclor","company":""},{"name":"cefdinir","slug":"cefdinir","company":""}],"globalPrevalence":null},{"indication":"Haemophilus Parainfluenzae Bronchitis","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"cefdinir","slug":"cefdinir","company":""},{"name":"cefuroxime","slug":"cefuroxime","company":"Covis Injectables"},{"name":"cefuroxime axetil","slug":"cefuroxime-axetil","company":"Glaxosmithkline"}],"globalPrevalence":null}],"mechanism":{"target":"Potassium voltage-gated channel subfamily H member 2","novelty":"Follow-on","targets":[{"gene":"KCNH2","source":"DrugCentral","target":"Potassium voltage-gated channel subfamily H member 2","protein":"Potassium voltage-gated channel subfamily H member 2"}],"modality":"Small Molecule","drugClass":"High Risk QT Prolonging Agents","explanation":"","oneSentence":"","technicalDetail":"Sparfloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, enzymes critical for bacterial DNA replication, transcription, repair, and recombination."},"commercial":{"launchDate":"1996","_launchSource":"DrugCentral (FDA 1996-12-19, )"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2466","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=SPARFLOXACIN","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=SPARFLOXACIN","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T15:42:45.370389","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:37:36.615032+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"ofloxacin","drugSlug":"ofloxacin","fdaApproval":"1990-12-28","genericCount":20,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ciprofloxacin","drugSlug":"ciprofloxacin","fdaApproval":"1987-10-22","patentExpiry":"Nov 27, 2038","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"enoxacin","drugSlug":"enoxacin","fdaApproval":"1991-12-31","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"norfloxacin","drugSlug":"norfloxacin","fdaApproval":"1986-10-31","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"lomefloxacin","drugSlug":"lomefloxacin","fdaApproval":"1992-02-21","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"grepafloxacin","drugSlug":"grepafloxacin","fdaApproval":"1997-11-06","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"levofloxacin","drugSlug":"levofloxacin","fdaApproval":"1996-12-20","genericCount":36,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"trovafloxacin","drugSlug":"trovafloxacin","fdaApproval":"1997-12-18","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"moxifloxacin","drugSlug":"moxifloxacin","fdaApproval":"1999-12-10","patentExpiry":"May 29, 2029","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"gemifloxacin","drugSlug":"gemifloxacin","fdaApproval":"2003-04-04","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"gatifloxacin","drugSlug":"gatifloxacin","fdaApproval":"2003-03-28","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"delafloxacin","drugSlug":"delafloxacin","fdaApproval":"2017-06-19","patentExpiry":"Sep 23, 2029","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"sparfloxacin","indications":{"approved":[{"name":"Acute Moraxella catarrhalis bronchitis","source":"DrugCentral","snomedId":195722003,"regulator":"FDA"},{"name":"Acute bacterial bronchitis","source":"DrugCentral","snomedId":233598009,"regulator":"FDA"},{"name":"Bacterial infection due to Klebsiella pneumoniae","source":"DrugCentral","snomedId":186435004,"regulator":"FDA"},{"name":"Chlamydia Pneumoniae Bronchitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Chlamydial pneumonia","source":"DrugCentral","snomedId":233609002,"regulator":"FDA"},{"name":"Enterobacter Cloacae Bronchitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Haemophilus Influenzae Bronchitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Haemophilus Parainfluenzae Bronchitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Haemophilus Parainfluenzae Pneumonia","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Haemophilus influenzae pneumonia","source":"DrugCentral","snomedId":70036007,"regulator":"FDA"},{"name":"Moraxella Catarrhalis Pneumonia","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Pneumonia","source":"DrugCentral","snomedId":233604007,"regulator":"FDA"},{"name":"Pneumonia due to Mycoplasma pneumoniae","source":"DrugCentral","snomedId":46970008,"regulator":"FDA"},{"name":"Pneumonia due to Streptococcus","source":"DrugCentral","snomedId":34020007,"regulator":"FDA"},{"name":"Staphylococcus Aureus Bronchitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Streptococcus Pneumoniae Bronchitis","source":"DrugCentral","snomedId":"","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"ofloxacin","brandName":"ofloxacin","genericName":"ofloxacin","approvalYear":"1990","relationship":"same-class"},{"drugId":"ciprofloxacin","brandName":"ciprofloxacin","genericName":"ciprofloxacin","approvalYear":"1987","relationship":"same-class"},{"drugId":"enoxacin","brandName":"enoxacin","genericName":"enoxacin","approvalYear":"1991","relationship":"same-class"},{"drugId":"norfloxacin","brandName":"norfloxacin","genericName":"norfloxacin","approvalYear":"1986","relationship":"same-class"},{"drugId":"lomefloxacin","brandName":"lomefloxacin","genericName":"lomefloxacin","approvalYear":"1992","relationship":"same-class"},{"drugId":"grepafloxacin","brandName":"grepafloxacin","genericName":"grepafloxacin","approvalYear":"1997","relationship":"same-class"},{"drugId":"levofloxacin","brandName":"levofloxacin","genericName":"levofloxacin","approvalYear":"1996","relationship":"same-class"},{"drugId":"trovafloxacin","brandName":"trovafloxacin","genericName":"trovafloxacin","approvalYear":"1997","relationship":"same-class"},{"drugId":"moxifloxacin","brandName":"moxifloxacin","genericName":"moxifloxacin","approvalYear":"1999","relationship":"same-class"},{"drugId":"gemifloxacin","brandName":"gemifloxacin","genericName":"gemifloxacin","approvalYear":"2003","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":["Osteomyelitis"],"enrollment":11,"completionDate":"2018-11-07"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NUI":"N0000148455","MMSL":"5504","NDDF":"005789","UNII":"Q90AGA787L","VUID":"4020985","CHEBI":"CHEBI:9212","VANDF":"4020985","INN_ID":"6612","RXNORM":"18469","UMLSCUI":"C0034428","chemblId":"CHEMBL850","ChEMBL_ID":"CHEMBL850","KEGG_DRUG":"D00590","DRUGBANK_ID":"DB01208","PUBCHEM_CID":"60464","SNOMEDCT_US":"387554008","IUPHAR_LIGAND_ID":"10860","MESH_SUPPLEMENTAL_RECORD_UI":"C061363"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","halfLife":"20.0 hours","clearance":"2.7 mL/min/kg","bioavailability":"92%","fractionUnbound":"0.55%","volumeOfDistribution":"3.9 L/kg"},"publicationCount":1278,"therapeuticAreas":["Infectious Disease"],"atcClassification":{"source":"DrugCentral","atcCode":"J01MA09","allCodes":["J01MA09"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturers":0,"_genericFilersChecked":true,"genericManufacturerList":[],"status":"approved","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1996","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1996-12-19T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1996-12-19T00:00:00.000Z","mah":"MYLAN","brand_name_local":"ZAGAM","application_number":"NDA020677"},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:37:36.615032+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}